Provided by Tiger Fintech (Singapore) Pte. Ltd.

Irhythm Technologies Inc.

162.35
+1.791.11%
Post-market: 162.350.00000.00%16:10 EDT
Volume:451.99K
Turnover:73.18M
Market Cap:5.22B
PE:-55.41
High:163.33
Open:162.01
Low:159.29
Close:160.56
52wk High:168.32
52wk Low:55.92
Shares:32.13M
Float Shares:31.75M
Volume Ratio:0.97
T/O Rate:1.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9300
EPS(LYR):-3.6315
ROE:-91.13%
ROA:-3.53%
PB:50.32
PE(LYR):-44.71

Loading ...

BRIEF-iRhythm Technologies Q2 Revenue USD 186.7 Million Vs. IBES Estimate USD 173.9 Million

Reuters
·
Aug 01

iRhythm Technologies Inc FY2025 REV View $695.7 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
Aug 01

iRhythm Technologies Inc - Projects FY 2025 Revenue Between $720 Mln-$730 Mln

THOMSON REUTERS
·
Aug 01

iRhythm Technologies Inc: Adj Ebitda Margin for FY 2025 Expected to Range From About 8.0% to 8.5% of Revenues

THOMSON REUTERS
·
Aug 01

iRhythm Technologies Q2 Gross Margin 71.2%

THOMSON REUTERS
·
Aug 01

iRhythm Technologies Announces Second Quarter 2025 Financial Results

GlobeNewswire
·
Aug 01

Inside Ophir's stellar FY25 with Andrew Mitchell (and 5 stock he likes right now)

LiveWire
·
Jul 23

Would iRhythm Technologies (NASDAQ:IRTC) Be Better Off With Less Debt?

Simply Wall St.
·
Jul 21

iRhythm Technologies Inc. to Report Second Quarter 2025 Financial Results

Reuters
·
Jul 18

BTIG maintains iRhythm estimates after CMS fee schedule proposal

TIPRANKS
·
Jul 15

IRhythm Technologies Inc. Files Initial Statement of Beneficial Ownership for Director Kevin C. O'Boyle

Reuters
·
Jul 09

iRhythm Technologies Announces Board Member Changes

TIPRANKS
·
Jul 08

Press Release: iRhythm Technologies Announces Board Member Retirements and New Director Appointments

Dow Jones
·
Jul 07

Top Executive Sells Significant Shares in Irhythm Technologies!

TIPRANKS
·
Jul 03

IRhythm Technologies Inc. EVP, CMO & CSO Minang Turakhia Reports Disposal of Common Shares

Reuters
·
Jul 03

iRhythm Technologies Inc. Files Initial Statement of Beneficial Ownership for Sean Clinton Freeman, EVP of Strategy & Corporate Development

Reuters
·
Jul 02

Chad Patterson, Chief Commercial Officer, Reports Disposal of Common Shares of IRhythm Technologies Inc

Reuters
·
Jun 25

iRhythm Technologies Unveils New Data at ADA 2025: Highlights Early Cardiac Arrhythmia Risks in Type 2 Diabetes and CKD Patients

Reuters
·
Jun 23

Chief Commercial Officer Chad Patterson Reports Disposal of Common Shares of iRhythm Technologies Inc

Reuters
·
Jun 12

iRhythm Technologies Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Jun 12